ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,420.03
-0.06%
Brent Oil
82.215
-0.28%
Bitcoin
70,140.29
0.01%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. iBio Inc (IBIO)

  7. iBio Inc (IBIO) News

iBio (IBIO)

iBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:IBIO
DateTimeSourceHeadlineSymbolCompany
20/05/202411:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
13/05/202421:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/05/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/05/202421:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:IBIOiBio Inc
13/05/202421:08Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
13/05/202421:05GlobeNewswire Inc.iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
27/03/202411:00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
26/03/202423:35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202412:59Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/02/202412:45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
21/02/202421:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
19/01/202421:36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
16/01/202413:15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
10/01/202418:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
08/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
04/01/202413:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
26/12/202312:44Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/12/202312:15GlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
08/12/202321:17Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
06/12/202314:13Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
06/12/202313:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
05/12/202313:00GlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
05/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
30/11/202313:55Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
28/11/202313:36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
27/11/202322:20GlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
03/11/202320:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
01/11/202312:24GlobeNewswire Inc.iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificAMEX:IBIOiBio Inc
27/10/202321:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:IBIOiBio Inc
26/10/202313:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:IBIOiBio Inc
 Showing the most relevant articles for your search:AMEX:IBIO

Your Recent History

LSE
PET
Petrel Resources
LSE
GGP
Greatland Gold
LSE
QBT
Quantum Blockchain Techn...
LSE
TYM
Tertiary Minerals
LSE
GMET
Golden Metal Resources
LSE
PXC
Phoenix Copper
LSE
AAU
Ariana Resources
LSE
AVCT
Avacta
LSE
SOLG
Solgold
LSE
HMI
Harvest Minerals
LSE
GSCU
Great Southern Copper
LSE
BIRD
Blackbird
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved